Trials / Completed
CompletedNCT01759316
Heliox in Preterm Infants With Respiratory Distress Syndrome
Nasal Intermittent Positive Pressure Ventilation and Mechanical Ventilation With Heliox in Preterm Infants With Respiratory Distress Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Third Military Medical University · Academic / Other
- Sex
- All
- Age
- 28 Weeks – 37 Weeks
- Healthy volunteers
- Not accepted
Summary
Heliox can lower respiratory resistance, improve the oxygenation, reduce respiratory distress and lung injury caused by mechanical ventilation.
Detailed description
Heliox can improve the oxygenation, reduce respiratory distress and lung injury caused by mechanical ventilation. Heliox has not been widely used. More studies on the effects and safety of Heliox in addition to NIPPV and mechanical ventilation should be tried.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | heliox | heliox or oxygen is used in the two groups respectively |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2013-01-03
- Last updated
- 2013-10-28
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01759316. Inclusion in this directory is not an endorsement.